Azithromycin and Ciprofloxacin Treatment Outcomes During an Outbreak of Multidrug-Resistant <i>Shigella sonnei</i> Infections in a Retirement Community—Vermont, 2018

Abstract

These azithromycin treatment failures demonstrate the importance of clinical breakpoints to aid clinicians in identifying alternative treatment options for resistant strains. Additionally, these treatment failures highlight a need for comprehensive susceptibility testing and systematic outcome studies, particularly given the emergence of multidrug-resistant Shigella among an expanding range of patient populations.